Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach

Diabetes

Volumn 48, Issue 5, 1999, Pages 1054-1060

  Nagasaka, Shoichiro ^a   Tokuyama, Kumpei ^b   Kusaka, Ikuyo ^a   Hayashi, Hiroko ^a   Rokkaku, Kumiko ^a   Nakamura, Tomoatsu ^a   Kawakami, Akio ^a   Higashiyama, Minori ^a   Ishikawa, San e ^a   Saito, Toshikazu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; SULFONYLUREA;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; KINETICS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; DEUTERIUM; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; MALE; MATHEMATICS; MODELS, BIOLOGICAL;

EID: 0032934847     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.5.1054     Document Type: Article

References (35)

1. Bergman RN: The minimal model: yesterday, today, and tomorrow. In The Minimal Model Approach and Determinants of Glucose Tolerance, Pennington Center Nutrition Series. Vol. 7. Bergman RN, Lovejoy JC, Eds., Baton Rouge, LA, Louisiana State University Press, 1997, p. 3-50
2. Finegood DT: Application of the minimal model of glucose kinetics. In The Minimal Model Approach and Determinants of Glucose Tolerance, Pennington Center Nutrition Series. Vol. 7. Bergman RN, Lovejoy JC, Eds. Baton Rouge, LA, Louisiana State University Press, 1997, p. 51-122
3. Best JD, Watanabe RM, Kahn SE, Ni T, Ader M, Bergman RN: Role of glucose effectiveness in the determinants of glucose tolerance. Diabetes Care 19:1018-1030, 1996
4. Finegood DT, Hramiak IM, Dupre J: A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. J Clin Endocrinol Metab 70:1538-1549, 1990
5. Taniguchi A, Nakai Y, Fukushima M, Kawamura H, Imura H, Nagata I, Tokuyama K: Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes 41:1540-1546, 1992
6. Taniguchi A, Nakai Y, Doi K, Fukushima M, Nagata I, Kawamura H, Imura H, Suzuki M, Tokuyama K: Glucose effectiveness in two subtypes within impaired glucose tolerance: a minimal model analysis. Diabetes 43:1211-1217, 1994
7. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR: Role of glucose and insulin resistance in development of type 2 diabetes: results of a 25-year follow-up study. Lancet 340:925-929, 1992
8. Ader M, Pacini G, Yang YJ, Bergman RN: Importance of glucose per se to intravenous glucose tolerance: comparison of the minimal-model prediction with direct measurements. Diabetes 34:1092-1103, 1985
9. Ward GM, Weber KM, Walters IM, Aitken PM, Lee B, Best JD, Boston RC, Alford FP: A modified minimal-model analysis of insulin sensitivity and glucose-mediated glucose disposal in insulin-dependent diabetes. Metabolism 40:4-9, 1991
10. Quon MJ, Cochran C, Taylor SI, Eastman RC: Non-insulin-mediated glucose disappearance in subjects with IDDM: discordance between experimental results and minimal model analysis. Diabetes 43:890-896, 1994
11. Finegood DT, Tzur D: Reduced glucose effectiveness associated with reduced insulin release: an artifact of the minimal-model method. Am J Physiol 271:E485-E495, 1996
12. Caumo A, Vicini P, Cobelli C: Is the minimal model too minimal? Diabetologia 39:997-1000, 1996
13. Vicini P, Caumo A, Cobelli C: The hot IVGTT two-compartment minimal model: indexes of glucose effectiveness and insulin sensitivity. Am J Physiol 273:E1024-E1032, 1997
14. Avogaro A, Bristow JD, Bier DM, Cobelli C, Toffolo G: Stable-label intravenous glucose tolerance test minimal model. Diabetes 38:1048-1055, 1989
15. Avogaro A, Vicini P, Valerio A, Caumo A, Cobelli C: The hot but not the cold minimal model allows precise assessment of insulin sensitivity in NIDDM subjects. Am J Physiol 270:E532-E540, 1996
16. Caumo A, Cobelli C: Hepatic glucose production during the labeled IVGTT: estimation by deconvolution with a new minimal model. Am J Physiol 264:E829-E841, 1993
17. Tsuruoka A, Matsuba I, Toyota T, Isshiki G, Nagasaki S, Ikeda Y: Antibodies to GAD in Japanese diabetic patients: a multicenter study. Diabetes Res Clin Pract 28:191-199, 1995
18. Wolfe RR: Radioactive and Stable-Isotope Tracers in Biomedicine: Principles and Practice of Kinetic Analysis. New York, Wiley-Liss, 1992
19. Cobelli C, Toffolo G, Bier DM, Nosadini R: Models to interpret kinetic data in stable isotope tracer studies. Am J Physiol 253:E551-E564, 1987
20. Vicini P, Sparacino G, Caumo A, Cobelli C: Estimation of endogenous glucose production after a glucose perturbation by nonparametric stochastic deconvolution. Comput Methods Programs Biomed 52:147-156, 1997
21. Overkamp D, Gautier JF, Renn W, Pickert A, Scheen AJ, Schmulling RM, Eggstein M, Lefebvre PJ: Glucose turnover in humans in the basal state and after intravenous glucose: a comparison of two models. Am J Physiol 273:E284-E296, 1997
22. Press WH, Flannery BP, Teukolsky SA, Vetterling WT: Numerical Recipes in Paascal. Cambridge, Cambridge University Press, 1989
23. Jeng C, Sheu WH, Fuh MM, Chen YI, Reaven GM: Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM. Diabetes 43:1440-1444, 1994
24. Perriello G, Pampanelli S, Sindaco PD, Lalli C, Ciofetta M, Volpi E, Santeusanio F, Brunetti P, Bolli GB: Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes 46:1010-1016, 1997
25. Barzilai N, Hawkins M, Angelov I, Hu M, Rossetti L: Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production. Diabetes 45:1329-1335, 1996
26. Marshall S, Bacote V, Traxinger RR: Discovery of a metabolic pathway mediating desensitization of the glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266: 4706-4712, 1992
27. Cryer PE, Fisher JN, Shamoon H: Hypoglycemia. Diabetes Care 17:734-755, 1994
28. Del Prato S, Matsuda M, Simonson DC, Groop LC, Sheehan P, Leonetti F, Bonadonna RC, DeFronzo RA: Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance. Diabetologia 40:687-697, 1997
29. Basu A, Caumo A, Bettini F, Gelisio A, Alzaid A, Cobelli C, Rizza RA: Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. Diabetes 46:421-432, 1997
30. Wise SD, Nielsen MF, Cryer PE, Rizza RA: Overnight normalization of glucose concentrations improves hepatic but not extrahepatic insulin action in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab 83:2461-2469, 1998
31. Caumo A, Cobelli C, Finegood DT: Minimal model estimate of glucose effectiveness: role of the minimal model volume and of the second hidden compartment. Am J Physiol 271:E573-E576, 1998
32. Cobelli C, Vicini P, Caumo A: If the minimal model is too minimal, who suffers more: Sg or Si? Diabetologia 40:362-363, 1997
33. Ni T, Ader M, Bergman RN: Reassessment of glucose effectiveness and insulin sensitivity from minimal-model analysis: a theoretical evaluation of the single-compartment glucose distribution assumption. Diabetes 46:1813-1821, 1997
34. Vicini P, Avogaro A, Valerio A, Caumo A, Cobelli C: Glucose effectiveness, clearance rate and peripheral insulin sensitivity are impaired in NIDDM subjects: a hot minimal model study (Abstract). Diabetes 45:100A, 1996
35. Nielsen MF, Basu R, Wise S, Caumo A, Cobelli C, Rizza RA: Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake. Diabetes 47:1735-1747, 1998